問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberPPHM 1202

2014-05-01 - 2017-04-20

Phase III

Terminated11

ICD-10C34.90

Malignant neoplasm of unspecified part of unspecified bronchus or lung

ICD-10C34.91

Malignant neoplasm of unspecified part of right bronchus or lung

ICD-10C34.92

Malignant neoplasm of unspecified part of left bronchus or lung

ICD-10C7A.090

Malignant carcinoid tumor of the bronchus and lung

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9162.9

Malignant neoplasm of bronchus and lung, unspecified

  • Trial Applicant

    PPD DEVELOPMENT (HK) LIMITED

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2025/08/20

Investigators and Locations

Principal Investigator 林孟志 Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 陳昭勳 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Chong-Jen Yu Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Gee-chen Chang Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Yuh-Min Chen Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Wu-Chou Su Division of General Internal Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 曹昌堯 Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Chien-Ying Liu Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator Ying-Huang Tsai Division of Thoracic Medicine

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 蘇穎文 Division of Hematology & Oncology

Co-Principal Investigator

  • 吳健樑 Division of Thoracic Medicine
  • 蘇健 Division of Thoracic Medicine

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Principal Investigator 蘇穎文 Division of Hematology & Oncology

Co-Principal Investigator

  • 蘇健 Division of Thoracic Medicine
  • 吳健樑 Division of Thoracic Medicine

The Actual Total Number of Participants Enrolled

0 Stop recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    60 participants

  • Global

    582 participants